Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
127828-22-2
139115-91-6
165963-71-3
108466-89-3
462100-06-7
1076199-21-7
1408058-13-8 | 2-(4-Piperidyl)benzoxazole hydrochloride | AA001CPK | MFCD22574986
1454690-49-3 | 1-Butanamine, 3-methoxy-3-methyl-, hydrochloride (1:1) | AA001CZ1 | MFCD28130380
145742-50-3 | 4-Amino-5-chloro-2-methoxybenzaldehyde | AA001DA9 | MFCD24645097
14606-42-9 | Silanethiol, 1,1,1-triphenyl- | AA001DKQ | MFCD00192551
146368-16-3 | Cy3-se | AA001DV8 | MFCD29472576
14670-94-1 | 3,5-Dimethyladamantane-1-carboxylic acid | AA001E6D | MFCD00188067
1470372-59-8 | Brettphos Pd(II) G3 | AA001EH1 | MFCD22572666
147372-41-6 | 2-Chloro-n-(4-methylphenyl)propanamide | AA001ES4 | MFCD03965281
1477-19-6 | Benzarone | AA001F1G | MFCD00867417
14804-31-0 | 4-Bromo-2-methylanisole | AA001FBM | MFCD01321139